# Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Inspection Records

Source: https://www.keypedia.com/companies/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/0de9118f-18ec-45b8-b757-44f97c13c29c

> Inspection records and compliance data for Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC in Andover, MA. Access full analysis and detailed observations.

---

## Details

- Name: Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
- FEI Number: 1222181
- City: Andover
- State: MA
- Country Name: United States
- Address Line 1: 1 Burtt Rd.
- Zip Code: 01810

## Related Documents

- [483 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Unknown Date](https://www.keypedia.com/records/483/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/963fbbb7-ae34-41b3-b159-0019c8524637) — source: FDA, date: Invalid Date
- [FDA Inspection 1311392 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2026-04-08](https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/c5b9683d-dfc5-496a-afe9-353614bb2207) — source: FDA, date: April 8, 2026
- [FDA Inspection 1304580 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2026-02-11](https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/7fe2f561-ac70-45eb-81ac-d14014ee75a6) — source: FDA, date: February 11, 2026
- [FDA Inspection 1304580 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2026-02-11](https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/97de66a3-38df-4231-8616-827b2267fbc3) — classification: No Action Indicated (NAI), source: FDA, date: February 11, 2026
- [FDA Inspection 1223617 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2023-10-13](https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/22d7cfbc-d24c-4694-920d-84b9472872b0) — classification: No Action Indicated (NAI), source: FDA, date: October 13, 2023
- [483 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2023-09-19](https://www.keypedia.com/records/483/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/c70a3b04-995f-41cd-952c-4d3acebbffce) — source: FDA, date: September 19, 2023
- [483 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2023-09-19](https://www.keypedia.com/records/483/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/7326d811-b200-4ac7-ae4e-783a9762d90c) — source: FDA, date: September 19, 2023
- [FDA Inspection 1218069 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2023-09-19](https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/4558354a-c1cd-4ed5-8d55-a88d769f59fc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 19, 2023
- [FDA Inspection 1218069 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2023-09-19](https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/f4363d29-0083-495d-94cb-2f6416bd0726) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 19, 2023
- [483 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2021-07-23](https://www.keypedia.com/records/483/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/bb58f9e8-aac6-4b29-8e8d-9fb5d728073e) — source: FDA, date: July 23, 2021
- [483 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2021-07-23](https://www.keypedia.com/records/483/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/f26688a9-ebef-4b85-8e02-60e31c3b8b06) — source: FDA, date: July 23, 2021
- [EIR - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2019-05-03](https://www.keypedia.com/records/eir/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/83e00d79-7a1e-4b09-9747-4ee3a4491903) — source: FDA, date: May 3, 2019
- [483 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2019-05-03](https://www.keypedia.com/records/483/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/f5c92731-0fa2-4ec9-acaf-b10ee4f44051) — source: FDA, date: May 3, 2019
- [EIR - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2019-01-18](https://www.keypedia.com/records/eir/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/392f3626-23c7-42dd-a7fd-44bea43a306e) — source: FDA, date: January 18, 2019
- [483 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2019-01-17](https://www.keypedia.com/records/483/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/a6583052-60a0-4c35-8b20-4c7cd6df9baf) — source: FDA, date: January 17, 2019
- [483 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2017-04-28](https://www.keypedia.com/records/483/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/c8d75329-d72d-429e-9706-037dbe88a7d5) — source: FDA, date: April 28, 2017
- [FDA Inspection 1020234 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2017-04-28](https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/b828d047-46c7-47e5-9c09-1a563eee27a5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 28, 2017
- [FDA Inspection 1020234 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2017-04-28](https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/f122bb42-1ac1-4ff2-a255-0f95cfbe9412) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 28, 2017
- [FDA Inspection 988784 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2016-09-30](https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/821cb434-f20b-4886-8feb-4ac5fdb96fd6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 30, 2016
- [FDA Inspection 919172 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2015-02-20](https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/a6219935-8f00-4291-b718-fec8e7927081) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 20, 2015

## Related Companies

- [Aptuit (Oxford) Ltd.](https://www.keypedia.com/companies/aptuit-oxford-ltd/da0ef59c-f35f-478c-a844-0d223aa34b67)
- [PolyPeptide Laboratories Private Limited](https://www.keypedia.com/companies/polypeptide-laboratories-private-limited/bf5a7a5c-b537-4d71-87ce-a45650fd2b07)
- [Cipla Ltd.](https://www.keypedia.com/companies/cipla-ltd/d90a952b-3052-4e33-9969-5db3f2bbae82)
- [Apitoria Pharma Private Limited](https://www.keypedia.com/companies/apitoria-pharma-private-limited/7a543877-97f7-4c4a-8dc8-74ee9d1c0caf)
- [SpecGx LLC](https://www.keypedia.com/companies/specgx-llc/715bb75a-8d3a-4469-9e6d-f617c2f39c93)
- [Tianish Laboratories Private Limited](https://www.keypedia.com/companies/tianish-laboratories-private-limited/3aa20920-7f85-4cd2-806b-a3cfb4548be8)
- [Shilpa Pharma Lifesciences Limited](https://www.keypedia.com/companies/shilpa-pharma-lifesciences-limited/4f617c67-eea7-483d-b9c7-b1dd31aabcff)
- [MedImmune U.K. Limited](https://www.keypedia.com/companies/medimmune-uk-limited/fbddd1ed-5a0c-4c65-a48e-bb2af79482ed)
- [Tianish Laboratories Private Limited](https://www.keypedia.com/companies/tianish-laboratories-private-limited/e097960f-98b1-47f2-877c-d588005879b6)
- [Lonza AG](https://www.keypedia.com/companies/lonza-ag/7084f7e6-ce36-429f-942a-28e759416e70)

## Related Officers

- [Gunther H. Boekhoudt](https://www.keypedia.com/people/gunther-h-boekhoudt/b845bcf5-191b-4f26-bdd7-22b1b082cc1d)
- [Nailing Zhang](https://www.keypedia.com/people/nailing-zhang/d3814d08-b799-4de1-b901-1b90da0e0178)
- [issuing_officer](https://www.keypedia.com/people/jee-y-chung/0736677f-9719-44dc-9dab-60b610ac1a0a)
- [issuing_officer](https://www.keypedia.com/people/aimee-cunningham/c49df6e2-a332-4f77-890f-213e3b3ddfb7)